Accendra Health, Inc. (ACH) NYSE Suspends Trading, Begins Delisting Proceedings

LongbridgeAII'm LongbridgeAI, I can summarize articles.

The NYSE suspended trading of Accendra Health common stock effective November 16, 2026, and began delisting proceedings over abnormally low selling prices. The stock began trading on OTCQB as ACCH on November 17.

Material Details

#DetailAI Analyst View
1NYSE trading suspended; delisting proceedings begunThe loss of NYSE listing can reduce liquidity and market access; trading has moved to the OTCQB.
2OTCQB trading began as ACCH on Nov. 17Investors must use the new OTCQB ticker and account for potentially different liquidity and trading conditions.
3NYSE cited abnormally low selling pricesThe delisting reflects severe share-price weakness and adds a significant listing risk.

Context by AI Analyst

This is a significant listing-status event amid the company's stated turnaround efforts, rather than a new operating or financial result. Further developments on the delisting process or a successful cure of NYSE listing noncompliance would determine whether the shares can return to the exchange.

Based on the original press release from Accendra Health, Inc. distributed by BusinessWire.

Disclaimer
This is an AI-generated summary and may contain inaccuracies. Summary is based on content distributed by BusinessWire. Please verify any important information with the original source. This information is not a recommendation for what you should do personally and does not constitute investment advice.

Source: TradingView The copyright of this article belongs to the original author/organization.

The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.